Selecting the optimum treatment for colorectal liver metastases

Surgical Oncology

Volumn 16, Issue , 2007, Pages 133-136

  Taylor, Irving ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Colorectal; Liver metastases

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER THERAPY; COLORECTAL LIVER METASTASIS; HUMAN; LIVER METASTASIS; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW;

CATHETER ABLATION; COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; NEOADJUVANT THERAPY; PREOPERATIVE CARE;

EID: 36649001629     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2007.10.040     Document Type: Review

References (27)

1. Bipat S., van Leeuwen M.S., Comans E.F., et al. Colorectal liver metastases: CT, MR imaging and PET for diagnosis-meta-analysis. Radiology 237 (2005) 123-131
2. Arulampalan T.H.A., Francis D.L., Taylor I., et al. FDG-PET for the pre-operative evaluation of colorectal liver metastases. European Journal of Surgical Oncology 30 (2004) 286-291
3. Jones O.M., Rees M., John T.G., et al. Biopsy of potentially operable hepatic metastases is not useless but dangerous. British Medical Journal 329 (2004) 1045-1046
4. Wood C.B., Gillis C.R., and Blumgart C.H. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clinical Oncology 2 (1976) 285-286
5. Taylor M., Fartner J., Langer B., et al. A study of prognostic factors for hepatic resection for colorectal liver metastases. American Journal of Surgery 173 (1997) 467-471
6. Fong Y., Cohen A.M., Fartner J.G., et al. Liver resection for colorectal liver metastases. Journal of Clinical Oncology 15 (1997) 938-946
7. Taylor I. Colorectal cancer and the liver. Annals of the Royal College of Surgeons 79 (1997) 315-318
8. Martin R., Paty P., Fong Y., et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastases. Journal of the American College of Surgeons 197 (2003) 233-241
9. Vibert E., Perniceni T., Lenard H., et al. Effect of surgical margins status on survival and site of recurrence after hepatic resection for colorectal metastases. British Journal of Surgery 93 (2006) 67-72
10. Yamamoto J., Sugihara K., Kosuge T., et al. Pathological support for limited hepatectomy in the treatment of liver metastases from colorectal cancer. Annals of Surgery 221 (1995) 74-78
11. Scheele J., Strange R., Alterdor-Hofman A., et al. Hepatic metastases from colorectal carcinoma, impact of surgical resection on the natural history. British Journal of Surgery 77 (1990) 1241-1246
12. Schindle M., Wigmore S.J., Currie E.J., et al. Prognostic scoring in colorectal liver metastases: development and validation. Archives of Surgery 140 (2005) 183-189
13. Solbiati L., Livraghi T., Goldberg S.N., et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 221 (2001) 156-166
14. Jansen M.C., van Duijhoven F.H., van Hillegersberg R., et al. Adverse effects of radiofrequency ablation of liver tumours in the Netherlands. British Journal of Surgery 92 (2005) 1249-1254
15. Oshowo A., Gillams A.R., Lees W.R., and Taylor I. Radiofrequency ablation extends the scope of surgery in colorectal liver metastases. European Journal of Surgical Oncology 29 (2003) 244-247
16. Oshowo A., Gillams A., Harrison E., and Taylor I. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. British Journal of Surgery 90 (2003) 1240-1243
17. Simmonds P.C. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. British Medical Journal 321 (2000) 531-535
18. Jonker D.J., Maroun J.A., and Kocha W. Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomised controlled trials. British Journal of Cancer 82 (2000) 1789-1794
19. Parks R., Gonen M., Kemery N., et al. Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents. Journal of the American College of Surgeons 204 (2007) 753-761
20. Moriya Y., Sugihara K., Aojo K., et al. Adjuvant hepatic intra-arterial chemotherapy alter potentially curative hepatectomy for liver metastases from colorectal cancer: a pilot study. European Journal of Surgical Oncology 17 (1991) 519-525
21. Kemeny M.M., Goldberg D., Beatty D., et al. Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. Cancer 57 (1986) 492-498
22. Shankar A., Leonard P., Renaut A.J., Ledermann J., et al. Neoadjuvant therapy improves resectability rates for colorectal liver metastases. Annals of the Royal College of Surgeons 83 (2001) 85-89
23. Folprecht G., Grothey A., Alberts S., et al. Neoadjuvant treatment of irresectable colorectal liver metastases: correlation between tumour response and resection rates. Annals of Oncology 16 (2005) 1311-1319
24. Adam R., Avisar E., Ariche A., et al. Five year survival following hepatic resection after neoadjuvant therapy for non-resectable colorectal liver metastases. Annals of the Surgical Oncology 8 (2001) 347-353
25. Giacchetti S., Itzhabi M., Gruia G., Adam R., et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Annals of Oncology 10 (1999) 663-669
26. Capassotti L., Muratore A., Mulas M.M., et al. Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases. British Journal of Surgery 93 (2006) 1001-1006
27. Garden O.J., Rees M., Poston G.R., et al. Guidelines for resection of colorectal cancer liver metastases. Gut 55 suppl (2006) 1-8